Radiotherapy and Oncology

Article	Citations
Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma	202
Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review	141
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	110
Contents	103
Aims+Scope/Editorial Board/ Publication information	85
Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters	75
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study	74
Dose response modelling of secretory cell loss in salivary glands using PSMA PET	72
Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment	71
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits	68
HaN-Seg: The head and neck organ-at-risk CT and MR segmentation challenge	67
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT	66
Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma	65
PD-0242 Comparison of static and dynamic proton arc treatment planning algorithms in oropharyngeal cancer	62
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors	60
X-ray on chip: Quantifying therapeutic synergies between radiotherapy and anticancer drugs using soft tissue sarcoma tumor spheroids	57
Response to “Comments on ‘Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort st	56
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas	53
MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer	50
Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives	49
Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT	49
Assessment of gaze direction during head and neck irradiation and dosimetric impact on the retina, macula and papilla in a cohort of 240 patients with paraoptic tumors	49
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis	47
MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advance	46
Factors associated with acute esophagitis during radiation therapy for lung cancer	46

Author’s response to Letter-to-the-Editor from Chang JS. concerning: “Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial”	44
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis	44
SP-0683 Combining immunotherapy with radiotherapy	43
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients	42
MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy	42
Ultra-fast pencil beam scanning proton therapy for locally advanced non-small-cell lung cancers: Field delivery within a single breath-hold	42
Radiosensitizing oxygenation changes in murine tumors treated with VEGF-ablation therapy are measurable using oxygen enhanced-MRI (OE-MRI)	42
Immunohistological profiling confirms salivary gland-like nature of the tubarial glands and suggests closest resemblance to the palatal salivary glands	41
PO-0244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up	40
Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer	40
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – A systematic review	40
Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system – A prospective multicenter study of 1075 patients	39
2225: Comparing the Hungarian RTT’s practice in the head and neck region with the ESTRO Guideline	38
1353: Impact of VOLOTMUltra optimizer for Radixact system on treatment plan quality and efficiency	38
3235: Predictors of executive function decline after brain RT: a novel NTCP analysis	37
1299: Individualised isotoxic radiotherapy for re-irradiation in recurrent pelvic cancers	37
1748: Collimated active spot-scanning IMPT vs VMAT for lung SBRT: Dosimetric and robustness comparison	36
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	36
2121: Should we switch to convolution algorithm when treating AVMs embolized with Onyx?	36
2724: Patient interchangeability between beam-matched accelerators	36
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	35
2933: Utility of circulating tumor HPV DNA for oropharynx cancer treated at an urban medical center	35
1676: Unexpected correlation between DWI and treatment response in HPV negative oropharyngeal carcinoma	35
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	35
729: Development of an automatic deformable registration workflow for multi-modal prostate imaging	34
749: Reinforcement learning for accelerated automatic treatment planning optimization	34
987: Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas Among EORTC Members	34
2172: Focused Ultrasound and RadioTHERapy for pain treatment in bone metastasis:an update of FURTHER trial	33
43: CPAP-assisted breathing and Supine Tangent Left Breast RT when DIBH-RT was Ineffective or Unsuitable	32
1998: Automation of Dose Stability Test in Helical Irradiations on Tomotherapy linear accelerators	32
438: Less pneumonia after nCRT and resection in oesophageal cancer using proton RT	31
347: The impact of molecular classification on adjuvant radiotherapy choice for early endometrial cancer	31
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	31
1045: Characterising spatial distribution of imaging parameters in cervical cancer	31
480: Simulating radiotherapy induced skin reactions with moulage on all skin types, Phase 1 findings.	30
1489: Impact of Cardiac Radiation Dose on Subclinical and Clinical Cardiotoxicity HER2+ Breast Cancer	30
893: The impact on overall survival of celiac plexus radiosurgery, post-hoc analysis of a clinical trial	30
419: surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter study	30
2180: Outcomes of salvage prostate re-irradiation for local recurrence after definitive radiation therapy	30
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	30
2808: Off-line plan evaluation with CBCT-Synthesized-CT in patients treated with DIBH for left breast	30
2959: The Impact of Advanced Algorithms on the Treatment of Meningiomas	29
330: External validation of rectal cancer CTV auto-contouring with patient-specific prior for online ART	29
2211: Investigation of chromosome aberration of different number of CBCT combined with therapeutic beams	29
65: Accuracy of SGRT versus MV EPID-based ball bearing positions for clinical range of couch rotations	29
3225: Commissioning of the Fricke solution dosimeter for particle therapy	28
2177: Impact Metal Implants on Radiotherapy Planning: HU Value Variations with 80kV and 140kV Tube Voltage	28
2395: Local control and toxicity after upper abdominal SBRT with Simultaneous Integrated Protection (SIP)	28
2533: Evaluation of set-up uncertainty in Radiosurgery using ExacTrac for validation of PTV margins	28
443: In-situ recalibration of PTW STARCHECK detector array by measuring set of beam profiles	28

2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	27
1807: Deep learning-based dose prediction for breast and regional lymph node radiotherapy	27
1254: Tumor Control Probability predictions for Hyperthermia plus Radiotherapy under varying conditions	27
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	27
3138: Mediastinal irradiation for thymic epithelial tumors: A deep focus on coronary arteries’ exposure	27
614: National guidelines for QA of deformable dose mapping: Feasibility and effect on dose prescription	26
2208: Implementing photobiomodulation as supportive care activity in an oncology-radiotherapy center	26
3310: Challenges and dilemmas in the elderly gynaecological cancer patient	26
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	26
560: Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer	26
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	26
3314: Child-friendly on-treatment solutions (RTT perspective)	26
1787: MR-guided stereotactic ablative radiotherapy for central lung tumors: long-term clinical outcomes.	26
2310: The development of a UK curriculum for therapeutic radiographers at an advanced level of practice.	25
2562: AI-enhanced proton radiography: deep learning for assessing treatment deviations in proton therapy	25
2219: Breaking boundaries: improve flow and create a positive work environment for radiation technologists	25
24: Experience on patient- specific QA for HyperArc stereotatic plans	25
938: Radiation-induced cerebral contrast enhancements strongly share ischemic stroke risk factors	25
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	24
940: Implementing plan of the day for cervix cancer: which contouring method and margins to use	24
773: FGFR2+ fibroblast-derived BMP5 promoted radioresistance in esophageal carcinoma	24
2997: Comprehensive cosmesis evaluation of ultrahypofractionated adjuvant breast radiotherapy with SIB	24
2848: Stereotactic body radiotherapy in elderly pancreatic cancer patients: single-institution experience	24
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	24
1348: Clinical application of a probabilistic robustness evaluation tool for proton therapy treatments	24
995: Enhancing outcomes: Neoadjuvant chemoradiation in locally advanced operable esophageal cancer.	24
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	24
3017: SABR of bony oligometastases, 1-year, efficacy, and toxicity analyses from the Bony-M trial	24
1127: Analysis of interstitial catheter number and dosimetric parameters in cervical cancer brachytherapy	24
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	24
3185: Retrospective analysis of output data for ten linear accelerators at Northern Ireland Cancer Centre	23
2119: Comparative Evaluation of 4DCT and 3D T1/T2w MRI in Delineation of Moving Target: A Phantom Study	23
2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT	23
2999: Craniospinal irradiation in Helical Tomotherapy: Dosimetric analysis and acute toxicity evaluation	23
1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks	23
1463: NG11-2 Phase Ib trial to reduce radiation-induced oral mucositis on patients with head & neck cancer	23
2128: Individual organ dose calculations from CT imaging of Hodgkin lymphoma patients treated with protons	23
70: Developing imaging biomarkers for the incidence of RP in patients with NSCLC who have underlying IPF	23
649: HDR brachytherapy as monotherapy in the treatment of prostate cancer	23
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	23
2422: Comparison of the patient movement in thorax treatments with free breathing and DIBH with SGRT	22
780: Proton radiotherapy in meningioma and hemangiopericytoma: a monocentric clinical report	22
2238: Efficacy and Safety of Low Dose Radiation Therapy for Alzheimer’s Disease: Phase II Clinical Trial	22
655: FET-PET and MRI integration in the planning process of HGG treated with adjuvant radiochemotherapy	22
134: The predictive value of Equivalent Uniform Dose (EUD) in Microbeam Radiation Therapy (MRT)	22
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	22
1193: Cytokines modulation by pelvic RT with simultaneous hypofractionated boost in prostate cancer	22
444: Sensitivity and specificity evaluation of PerFRACTION in a HALCYON 2.0	22
2681: Management of air in rectum and anal canal during adaptive radiotherapy.	21
3123: Stereotactic body radiotherapy for extracranial, intracranial or mixed-pattern oligometastatic NSCLC	21
3119: Large bicentric study on dosimetric changes during head and neck radiotherapy	21
735: Patterns of care and outcome of liver SBRT: results from a multicentre national quality project.	21
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	21
1329: Development of a Mobile Application to Support Prostate Cancer Patients Undergoing Radiotherapy	21
479: Field output correction factors of small static field for IBA Razor NanoChamber	21
680: SAPPHIRE - Establishment of Small Animal Proton and PHoton IRradiation Experiments	21
1856: Radiation therapists implication in research and transversal projects - Experience of Caen Center	21
768: Proton minibeam radiation therapy is a promising approach for re-irradiations	20
2060: Stereotactic Body Radiation Therapy (SBRT) for pain control in spinal metastases	20
3078: Enhancing Treatment Quality and Patient Safety: Streamlined Process Using 3D In-Vivo Dosimetry	20
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	20
2581: PET/MR imaging biomarkers of radioresistance in anal cancer patients	20
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	20
80: Overview of tumour sterilization rates in rectal cancers among treatment modalities; is more better?	20
3231: Creating similarly robust plans for different radiotherapy delivery systems	20
2529: ‘Tribrid’ teaching: The optimal model for 21st century clinical oncology education?	20
2035: Salvage stereotactic radiosurgery after whole brain radiotherapy in non-small cell lung cancer	20
1715: Pathological Phenotypes and Radiation Sensitivity of Airway Stem Cells Derived from COPD Patients.	20
1043: External validation of automated treatment planning for HDR prostate brachytherapy using BRIGHT	20
2522: Optimal pressure of CPAP for reduction mean heart dose in left-sided breast cancer radiotherapy	19
2175: SBRT vs SBRT + HDR-boost: a prospective comparative analysis of toxicity, QoL and disease control.	19
1695: Time-resolved analysis of clinical dose metrics for HDR brachytherapy error detection	19
2543: Characterization of the oxygen transport variation with dose on a cohort of breast cancer patients	19
2769: TRIBBLES1 (TRIB1) pseudokinase- mediated modulation of p53 function through COP1 and/or HDAC1 in GBM	19
385: Teaching and AI-Assistance Improve Organs-At-Risk Contouring for Head-Neck Cancer in a Global Study	19
1876: On table adaptation in MR Guided prostate cancer treatments. Can RTTs replace the physician?	19
3318: Collaborative research initiatives: Unleashing the potential of RTTs worldwide	19
1568: Toward multi-institutional Knowledge-Based benchmark for right and left whole breast irradiation	19
1142: Treatment-related parameters and acute toxicity in salvage radiotherapy of prostate cancer	19
1635: In vivo dosimetry - keeping my finger on the pulse	19

1599: Optimization of the comparison metric for EPID in vivo dosimetry of lung treatment	19
771: Hypofractionated dose-escalated salvage RT for macroscopic prostate cancer local recurrence	18
90: Delta CT radiomics features predicts prognosis after neoadjuvant chemotherapy in gastric-cancer	18
1059: Predictive value of tumor volume change during chemoradiotherapy in non-small cell lung cancer	18
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	18
3046: Factors influencing adaptive radiotherapy and tumor dynamics in cervical cancer treatment	18
3149: The toxicity and value of interstitial brachytherapy boost for high-risk breast cancer patients	18
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	18
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	18
2803: Treatment outcomes of intra-arterial chemoradiotherapy for oral cavity squamous cell carcinoma.	18
1749: Dosimetry and survival in unresectable primary HCC patients undergoing resin 90Y SIRT	18
2601: Guidelines-based automatic segmentation improvements	18
722: Standard versus highly hypofractionated tumor irradiation in LA-NSCLC with durvalumab consolidation	18
3490: Risk-adapted and response-adapted strategies for stage 3 NSCLC	18
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	18
284: Time-dependent diffusion MRI for tumor characterization in biologically adapted radiotherapy	18
3040: Radiotherapy-related quality of life in patients with Gynecological cancer	18
3335: Fairness in radiotherapy data use analysis & outcome modelling	17
511: Enhanced IMPT dose fall-off by optimised integration of Bragg peaks and transmission pencil beams	17
3093: Derivation of radiomic classifiers for radiotherapy response in locally advanced rectal cancer	17
503: A study comparing response for weekly v/s three weekly cisplatin in accelerated CRT for HNSCC	17
2053: An Italian multi-department study for relative dosimetry in tomotherapy	17
3162: Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer	17
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	17
1028: Is volumetric repainting needed to minimize interplay induced dose effects in lung proton therapy?	17
3128: Self-applied photobiomodulation therapy for radiation toxicity in head and neck cancer patients	17
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	17
2797: Initial Clinical and Dosimetric outcomes with TBI planned on Helical Tomotherapy	17
1096: Classical prognostic factors outperform SUV-max in LACC: an observational study	17
1442: EBUS-guided fiducial placement for SBRT in mediastinal nodal oligometastases	16
916: Dosimetric characterization of the FLASHKNiFE 10 MeV UHDR beam towards clinical translation	16
3315: Greening our hospitals: circular economy in healthcare & green skills for RTT – What we know?	16
1060: Validation of a parameterised automated VMAT technique for SIB radiotherapy of head and neck cancer.	16
1639: Robust VMAT dose planning on breast patients and selection of optimization bolus.	16
1850: Factors predict Complete Histological Response following neoadjuvant radiotherapy for rectal cancer	16
1979: Predicting radionecrosis following different radiotherapy dose for intracranial meningiomas	16
3622: Single-cell analysis of lung responses to radiation injury	16
890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer	16
2559: Outcomes of intracranial germ cell tumours treated at a single UK proton centre	16
2932: Oligometastatic liver SABR: clinical outcomes and evaluation of relapse pattern	16
159: Measurement of output factor for Cyberknife using scintillation dosimetry and deep learning	16
1603: Early cardiac functional and gene expression markers after irradiation of cardiac substructures	16
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	16
3470: Quality of life and cosmetic assessment in skin cancer treatment	16
1271: Improving breast cancer radiotherapy: determine need for plan adaptation based on corrected CBCTs	16
1952: Leveraging hybrid PET/MR imaging to distinguish progression from radionecrosis post-radiosurgery	16
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	16
3277: A cyber-attack response plan: How to ensure that patients continue to be treated (correctly)	16
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	16
2434: The radiobiological principles of low dose radiotherapy for non-cancer diseases	15
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	15
139: Stereotactic radiosurgery in elderly patients with brain metastases from non-small cell lung cancer	15
2476: Enhancing Patient Education: Assessing radiation therapists' understanding of hospital guidance.	15
1215: Oligometastatic Mesothelioma treated with Ablative Radiotherapy (OMAR): multi-institutional database	15
552: First-in-human breast imaging study with ultra-low field MRI for compact proton therapy systems	15
1573: Automated audit of planned versus delivered radiotherapy	15
1728: Development of a Preclinical X-ray Minibeam Monte Carlo Treatment Planning System using Topas	15
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	15
2025: Dosiomics models for prediction of skin toxicity after radiotherapy in breast cancer patients	15
1785: Comparison between Ethos measurements and dosimetric parametres calculated with Acuros XB Beam Model	15
2428: Radiotherapy or cystectomy in muscle-invasive bladder cancer: Outcomes with two clinical pathways	15
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	15
95: Phase Ib trial of Durvalumab plus tremelimumab with particle therapy for advanced HCC: DEPARTURE	15
1243: Evaluation of organ at risk contours in breast cancer patients: the role of radiation therapist	15
2981: Inflammatory indexes prognostic value in STS patients treated with preoperative chemoradiation	15
1861: Performance of a heart substructures autocontouring tool after clinical implementation	15
335: 0 mm PTV margin to reduce toxicity in MRI-guided RT for favorable intermediate-risk prostate cancer	15
2278: Decision aids and treatment regret in patients with localised prostate cancer: a systematic review	15
2679: ROLE OF STEREOTACTIC RADIOTHERAPY IN OLIGO-RECURRENCE OF PLEURAL MESOTHELIOMA	15
1689: Double Shell Positioning System versus Thermoplastic Shell For Brain Radiotherapy	15
529: Use of a radar plot to assess cervical HDR brachytherapy plans and correlate with clinical outcomes	15
1377: Dose Prediction for Prostate Radiotherapy Planning	15
1305: Impact of Abdominal Compression in SBRT for upper abdominal tumors	15
3061: Gut microbiome and gene expression changes during a Phase 1 trial of enadenotucirev and radiotherapy	15
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	15
3237: Pulsatile exposure to acid and radiation response in cells resembling oesophageal adenocarcinoma	14
2008: A Generative Adversarial Network for Radiotherapy Dose Predictions of Head and Neck Cancers	14
1014: Dosimetric evaluation of accelerated partial breast irradiation using VMAT technique	14
3621: ESTRO-ACROP recommendations for evidence-based use of antiandrogen deprivation therapy in combination with external-beam radiotherapy in prostate cancer	14
2284: Comparison of Diffusion-weighted MRI using SPLICE and SS-EPI in Tumors of the Head and Neck.	14
1647: Proton beam therapy image-guided radiotherapy training for RTTs: Experience from a single centre	14
336: Radiation-induced lymphopenia predicts poor survival in HCC patients treated with radiotherapy	14
3201: Dosimetric properties of flexible 3D-printed boluses	14
2275: Novel radiation quality metrics significantly increases performance of in vitro RBE proton models	14
3502: Standardising complex treatments like Total Body Irradiation (TBI) and Total Marrow and Lymph node Irradiation (TMLI)	14
1763: A compact gamma-ray detector coupled with a pinhole collimator for real-time dose monitoring in BNCT	14
2185: Internal motion variations associated with respiratory phase changes during amplitude gating VMAT	14
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	14
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	14
1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction	14
3336: Finding the right tool for patients and health care professionals	14
2752: A phantom study of robust analysis of Lung SBRT BH plan	14
2232: Emotional intelligence and empathy: are radiation therapists of the future emotionally sustainable?	14
3614: ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma	14
3023: ENRT vs MDT for prostate cancer lymph nodal relapses: a preliminary analysis	14